Zydus Cadila gets FDA final approval for Decitabine injection
Zydus Cadila has secured final approval from the US Food and Drug Administration (FDA) for the commercialization of the cancer medication Decitabine for Injection in ... Read More
Trovagene’s Onvansertib-decitabine combination trial shows promising results
Trovagene, a California-based cancer research company, has announced the successful completion of the second dosing cohort in its Phase 1b/2 trial investigating the Onvansertib-decitabine combination ... Read More